The third ongoing vaccine, Bharat Biotech’s Covaxin, which is being developed in collaboration with the Indian Council for Medical Research (ICMR), is simultaneously undergoing Phase 3 human trials at 22 sites in India with around 26,000 volunteers. . According to a senior company official, it will be at least 60 …
Read More »
Among the Center’s elaborate plan to distribute the vaccine against the coronavirus disease (Covid-19), are the country’s air and road transport network and the sites where the vaccine will be administered to eligible people in the first phase. On Friday, the subject matter expert committee (SEC) of the Central Medicines …
Read More »
The National Medicines Regulator’s Committee of Subject Matters (SEC) will meet again on Friday to make a decision on the Serum Institute of India (SII) Oxford-AstraZeneca’s Emergency Use Authorization Application (EUA) and Candidate Bharat Biotech vaccines against coronavirus disease. (COVID-19). The SEC had met for a second time on Wednesday …
Read More »
It’s December 31, the end of the year, and India may be just a day away from approving a vaccine. The Subject Matter Experts Committee (SEC) of the Central Medicines Standard Control Organization (CDSCO) on Wednesday reviewed data submitted by the Serum Institute of India and Bharat Biotech as requested …
Read More »
NEW DELHI: India is likely to have a Covid-19 vaccine in the new year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »
Prime Minister Narendra Modi laid the foundation stone for the Indian Institute of Medical Sciences (AIIMS) in Rajkot in Gujarat on Thursday, where he said people should show caution and strictly adhere to preventive coronavirus standards even after they are administered. vaccines. “I used to say ‘jab tak davai nahi …
Read More »
India is likely to get a coronavirus disease (Covid-19) vaccine in the New Year, the country’s top drug regulator hinted during a webinar on the science behind the vaccine’s development that allowed it to arrive from the lab. to people in less than 12 months. “We will have a Happy …
Read More »
AstraZeneca Plc will soon publish data showing that the effectiveness of its covid-19 vaccine increases up to 95% if the two injections are separated by approximately 2-3 months, said Adar Poonawalla, executive director of the Serum Institute of India (SII), partner. manufacturing company British. “You will be getting good news …
Read More »
Coronavirus: Adar Poonawalla Says Serum Institute Will Give First 50 Million Doses Of Covishield To India New Delhi: Stating that the delay in approval of the COVID-19 Oxford-AstraZeneca vaccine, produced en masse by his company, was not concerning, Adar Poonawalla from the Serum Institute of India (SII) said the inoculant …
Read More »
The first indigenous pneumonia vaccine, developed by the Serum Institute of India (SII), was launched by the Union’s health minister, Harsh Vardhan, on Monday. The vaccine will be sold under the name ‘Pneumosil’ and will be available as a single dose in a vial and pre-filled syringe or as a …
Read More »